Publications by authors named "Lorenzo So Marconi"
Background: Several comparative randomised controlled trials (RCTs) have been performed including combinations of tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors since the publication of a Cochrane Review on targeted therapy for metastatic renal cell carcinoma (mRCC) in 2008. This review represents an update of that original review.
Objectives: To assess the effects of targeted therapies for clear cell mRCC in patients naïve to systemic therapy.